Bowing to the clamour for scrutiny of the accounts of private power distribution companies operating in the city, the Delhi government has finally approved their audit by the Comptroller and Auditor General (CAG). According to a cabinet note, the government sanctioned an audit of the three discoms — BSES Yamuna and Rajdhani, and NDPL — “since inception.” The decision to get a CAG audit carried out was disclosed during a hearing in...
More »SEARCH RESULT
Total Matching Records found : 4494
Gujarat 2002 and Modi’s Misdeeds by Anand Teltumbde
Ten years after the killings in Gujarat, Narendra Modi has neither expressed regret nor has he been held accountable for those mass deaths. Where do we go from here? Anand Teltumbde (tanandraj@gmail.com) is a writer and civil rights activist with the Committee for the Protection of Democratic Rights, Mumbai. Just thinking of it, a shiver runs down my spine. I had my own brush with how the Hindutva gangs carried out the...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »Need regulation to make sure that financial inclusion becomes cost-effective by Ashok Khemka
One of the key factors to inclusive growth is financial inclusion for all. Financial inclusion refers to universal access to a wide range of banking solutions and financial services in a fair, predictable and transparent manner at affordable costs. The poor tend to be ignored because the transaction costs in serving them are high. Initiatives that reduce these costs will allow service providers to begin thinking of financial services for...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »
